⚕️ FREE MSRA PODCAST – IgA Nephropathy
🎧 A focused breakdown of this immune-mediated glomerular disease — perfect for MSRA prep and clinical recall!

🧠 Key Learning Points

📌 Definition
• Also known as Berger’s Disease
• Immune complex glomerulonephritis due to IgA deposition in the glomeruli
• Most common cause of primary glomerulonephritis globally

📌 Causes & Risk Factors
• Multifactorial: genetic predisposition + immune dysregulation
• Infections (especially respiratory or GI) trigger flare-ups
• Male sex (2:1 ratio), Asian descent, family history
• Associated with: coeliac disease, alcoholic liver disease, HSP, dermatitis herpetiformis

📌 Pathophysiology
• Abnormally glycosylated IgA1 → immune complex formation
• Deposits in mesangium → mesangial activation, inflammation, fibrosis
• Leads to glomerular scarring over time (Oxford classification: MEST)

📌 Symptoms
• Visible haematuria (especially after infections)
• Microscopic haematuria, proteinuria, hypertension
• Oedema, fatigue in more severe/progressive cases
• Often asymptomatic early — picked up on routine urinalysis

📌 Differential Diagnosis
• Post-infectious GN
• Lupus nephritis, HSP nephritis, membranoproliferative GN
• Myeloma, HIV nephropathy

📌 Diagnosis
• Urinalysis: blood, protein, red cell casts
• U&Es, eGFR, IgA levels (may be ↑ but not diagnostic)
• Definitive: renal biopsy with IgA deposits (±C3) on immunofluorescence
• Oxford MEST-C scoring = prognostic value
• Consider serum electrophoresis if age >50

📌 Management
• Mild disease: monitor (if low proteinuria, normal BP/renal function)
• If proteinuria >0.5–1g/day → ACEi or ARB (↓ proteinuria & protect kidney)
• If progressing: corticosteroids (e.g. prednisolone)
• Immunosuppressants only in rapidly progressive GN
• Lifestyle: low salt diet, weight control, stop smoking
• Rare cases: tonsillectomy (only if recurrent tonsillitis)
• ESRD → dialysis or transplant (but disease may recur post-transplant)

📌 Complications
• Chronic kidney disease, end-stage renal failure
• Hypertension, nephrotic syndrome, cardiovascular disease
• Risk of recurrence post-transplant

📌 Prognosis
• Highly variable
• Good: isolated haematuria, well-controlled BP, low proteinuria
• Poor: male sex, proteinuria >1g/day, uncontrolled HTN, ↓ eGFR, Oxford score with S/T lesions
• ~25–40% develop ESRD within 20 years

📎 More MSRA Resources for IgA Nephropathy

📝 Revision Notes:
https://www.passthemsra.com/topic/lga-nephropathy-revision-notes/

🧠 Flashcards:
https://www.passthemsra.com/topic/lga-nephropathy-flashcards/

💬 Accordion Q&A Notes:
https://www.passthemsra.com/topic/lga-nephropathy-accordion-qa-notes/

🚀 Rapid Quiz:
https://www.passthemsra.com/topic/lga-nephropathy-rapid-quiz/

🧪 Topic Quiz:
https://www.passthemsra.com/quizzes/iga-nephropathy/

🎓 Full Renal Course:
https://www.passthemsra.com/courses/renal-for-the-msra/

🩺 All resources are part of the Renal for the MSRA course on PassTheMSRA.com
📚 Explore full revision guides, quizzes, flashcards, and more:
https://www.passthemsra.com

Hashtags
#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAFlashcards #MSRAQandANotes #MSRAAccordions #Renal #IgANephropathy #BergerDisease #MSRAOnlineRevision #PassTheMSRA

⚡ FREE MSRA PODCAST – Hypokalaemia
🎧 A clear, high-yield breakdown of this common and potentially life-threatening electrolyte disturbance – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• Hypokalaemia refers to low blood potassium – defined as <3.5 mmol/L
• Categorised by severity:
– Mild: 3.1–3.5 mmol/L
– Moderate: 2.5–3.0 mmol/L
– Severe: <2.5 mmol/L
• Even mild cases increase cardiac arrhythmia risk 💓

📌 Causes & Risk Factors
• Renal losses: loop/thiazide diuretics, hyperaldosteronism (e.g. Conn’s), renal tubular acidosis
• GI losses: diarrhoea, vomiting, laxative abuse, bowel fistulae
• Skin losses: burns, profuse sweating
• Transcellular shift: insulin + glucose (e.g. DKA treatment), alkalosis, salbutamol use
• Reduced intake: malnutrition, anorexia, prolonged IV fluids without K⁺
• Miscellaneous: alcohol misuse, peritoneal dialysis
• Congenital: Gitelman’s and Bartter’s syndromes
🧠 Mnemonic: “DISH” – Diuretics, Intake ↓, Shifts, Hyperaldosteronism

📌 Pathophysiology
• 98% of potassium is intracellular
• Only 2% in extracellular fluid (what we measure)
• Na⁺/K⁺ ATPase pump maintains this gradient
• Kidneys (regulated by aldosterone) control K⁺ excretion
• Losses or shifts lead to impaired membrane potential → muscle + cardiac issues

📌 Symptoms
• Often asymptomatic if mild
• Moderate: fatigue, muscle weakness, constipation
• Severe: paralysis, respiratory muscle weakness, arrhythmias
• Other signs: muscle cramps, palpitations, polyuria
• Important risk: digoxin toxicity
🧠 Always check K⁺ in elderly or those on diuretics/digoxin!

📌 Differential Diagnosis
• Diuretic overuse
• Diarrhoea or vomiting
• DKA treatment (insulin shift)
• Primary hyperaldosteronism
• Anorexia, malnutrition
• Bartter’s/Gitelman’s syndromes
• Renal tubular disorders

📌 Diagnosis
• Bloods: U&Es (confirm low K⁺), serum magnesium, bicarbonate, glucose, chloride
• Check Mg²⁺: must be corrected for proper K⁺ repletion
• ECG:
– Flattened T waves
– ST depression
– U waves
– Risk of ventricular arrhythmias if <3.0 mmol/L
• Urine potassium:
– Low urine K⁺ → GI loss or transcellular shift
– High urine K⁺ → renal loss
• Urine sodium: low Na⁺ + high K⁺ may indicate volume depletion
• Further: renin/aldosterone, cortisol, adrenal imaging for endocrine causes

📌 Management
• Treat underlying cause and replace potassium
• Mild (3.1–3.5):
– Oral K⁺ supplements (e.g. KCl), dietary advice (bananas, tomatoes 🥑🍌🍅)
– Monitor levels regularly
• Moderate (2.5–3.0):
– Urgent review, oral or IV K⁺ replacement, assess cause
• Severe (<2.5):
– Hospital admission, IV potassium chloride (monitor cardiac rhythm)
– May need central line for high doses
• Always correct magnesium concurrently
• Avoid combining K⁺-sparing diuretics + supplements (risk of hyperkalaemia)
• Prevention:
– Consider spironolactone or amiloride with high-dose diuretics
– Regular monitoring in at-risk groups

📌 Complications
• Cardiac arrhythmias – esp. in those on digoxin
• Rhabdomyolysis
• Paralysis, respiratory compromise
• Nephrogenic diabetes insipidus
• Metabolic alkalosis
• Hepatic encephalopathy (in cirrhosis)
• Iatrogenic hyperkalaemia if overcorrected

📌 Prognosis
• Good if recognised early and managed appropriately

📎 More MSRA Resources📝 Revision Notes:
https://www.passthemsra.com/topic/hypokalaemia-revision-notes/

🧠 Flashcards:
https://www.passthemsra.com/topic/hypokalaemia-flashcards/

💬 Accordion Q&A Notes:
https://www.passthemsra.com/topic/hypokalaemia-accordion-qa-notes/

🚀 Rapid Quiz:
https://www.passthemsra.com/topic/hypokalaemia-rapid-quiz/

🎓 Full Course:
https://www.passthemsra.com/courses/renal-for-the-msra/

#MSRA #MSRARevisionNotes #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #Renal #Hypokalaemia

⚕️ FREE MSRA PODCAST – Hypertensive Nephropathy
🎧 A clear, high-yield breakdown of this kidney complication caused by chronic hypertension – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• Hypertensive nephropathy is kidney damage caused by long-term high blood pressure, leading to progressive nephron loss and chronic kidney disease (CKD).

📌 Causes & Risk Factors
• Sustained uncontrolled hypertension (primary cause)
• Advanced age
• African or Hispanic ethnicity
• Diabetes mellitus
• Obesity
• Smoking
• Family history of renal disease
🧠 Mnemonic: "HARDOCKS" – HTN, Age, Race (Afro-Caribbean/Hispanic), Diabetes, Obesity, CKD FHx, Smoking

📌 Pathophysiology
• Endothelial damage from chronic pressure
• Inflammation and oxidative stress
• Renal fibrosis and nephrosclerosis
• Reduced renal perfusion → nephron loss → CKD
• Eventually may lead to end-stage renal disease (ESRD)

📌 Symptoms
• Often asymptomatic in early stages
• Proteinuria (albuminuria)
• Difficult-to-control hypertension
• Oedema (especially legs)
• Fatigue, nausea, loss of appetite
• Uraemic symptoms in advanced cases (metallic taste, pruritus, drowsiness)
🧠 Think: "HIGH PRESS" – HTN, Increased proteinuria, General fatigue, Haematuria, Pruritus, Reduced output, Edema, Systemic symptoms

📌 Differential Diagnosis
• Diabetic nephropathy
• Glomerulonephritis
• Polycystic kidney disease
• Renovascular disease (bilateral renal artery stenosis)

📌 Diagnosis
• BP monitoring (confirm chronic hypertension)
• Blood tests: eGFR, serum creatinine, urea, potassium, phosphate, FBC
• Urine ACR (albumin:creatinine ratio)
• Renal ultrasound (check kidney size, scarring, obstruction)
• Pregnancy test in women of childbearing age
• Consider biopsy if diagnosis unclear
🧠 Tip: CKD + Proteinuria + Long-standing HTN = Think hypertensive nephropathy

📌 Management
• BP Target: <130/80 mmHg
• Lifestyle changes: exercise, low-salt diet, weight loss, stop smoking
• First-line meds: ACE inhibitors or ARBs (don’t combine)
• Loop diuretics (e.g., furosemide) for fluid overload
• Monitor potassium and renal function closely
• Low-protein diet (dietitian guided)
• Renal replacement therapy (dialysis/transplant) in ESRD
• Avoid ACE/ARB in pregnancy
🧠 Mnemonic: "PRESSURE" – Protein control, Reduce BP, Exercise, Stop smoking, Salt restriction, Use ACEi/ARB, Refer if needed, ESRD prep

📌 Complications
• Progression to ESRD
• Cardiovascular disease (MI, stroke)
• Electrolyte imbalances
• Anaemia
• Malnutrition
• Fluid overload and metabolic acidosis

📌 Prognosis
• Variable – depends on BP control and early detection
• Good BP control can slow disease progression
• Poorly managed cases often progress to ESRD
• CV risk remains high throughout

📎 More MSRA Resources for Hypertensive Nephropathy
📝 Revision Notes: https://www.passthemsra.com/topic/hypertensive-nephropathy-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/hypertensive-nephropathy-flashcards/
💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/hypertensive-nephropathy-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/hypertensive-nephropathy-rapid-quiz/
🎓 Full Course: https://www.passthemsra.com/courses/renal-for-the-msra/

#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQ&ANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #Renal #HypertensiveNephropathy

✅ MSRA Deep Dive: Hyperkalaemia – Emergency Recognition & Management
In this episode, we break down hyperkalaemia — a potentially life-threatening electrolyte imbalance — using a high-yield, structured format designed for the MSRA exam. Learn how to recognise, diagnose, and treat hyperkalaemia effectively using key numbers, clear ECG changes, and a stepwise treatment approach. Based on UK guidelines and core exam knowledge, this is your focused guide to a common emergency you must not miss.

🧠 Key Learning Points

📌 Definition & Thresholds
• Hyperkalaemia = serum K⁺ > 5.5 mmol/L
• Severity:

• Mild: 5.5–5.9 mmol/L

• Moderate: 6.0–6.4 mmol/L

• Severe: ≥6.5 mmol/L or with ECG changes (medical emergency)

📌 Causes
• Reduced excretion:

• AKI, CKD

• ACE inhibitors, ARBs, spironolactone
  • Redistribution:

• DKA, acidosis, digoxin toxicity, beta-blockers
  • Increased load:

• Potassium supplements, rhabdomyolysis, tumour lysis syndrome, crush injury
  • Pseudohyperkalaemia:

• Artefact from hemolysis, prolonged tourniquet, or lab delay

📌 Risk Factors
• Elderly, diabetics, renal impairment
• Dehydration, strenuous exercise, sickle cell trait
• Drugs: ACE inhibitors, potassium-sparing diuretics, NSAIDs

📌 Pathophysiology
• Potassium affects resting membrane potential
• Raised extracellular K⁺ makes cells less excitable but slows repolarisation
• Leads to muscle weakness, paralysis, and cardiac arrhythmias

📌 Symptoms
• Often asymptomatic
• Muscle weakness → paralysis
• Fatigue, palpitations, chest pain
• Bradycardia, arrhythmias, respiratory compromise
• ECG may be normal despite severe hyperkalaemia

📌 ECG Changes
Progression:

1. Tall, tented T waves

2. Prolonged PR interval

3. Loss of P wave

4. Widened QRS

5. Sine wave pattern → Cardiac arrest
   🛑 A normal ECG does not exclude dangerous hyperkalaemia!

📌 Investigations
• Repeat potassium to exclude pseudohyperkalaemia
• U&Es, creatinine, glucose, FBC, digoxin level
• ABG for acidosis and comparison
• 12-lead ECG – even if asymptomatic

📌 Management Framework
Step 1: Stabilise Cardiac Membranes

• IV calcium gluconate (30 mL 10%)

• Protects the myocardium but does not lower K⁺

Step 2: Shift K⁺ Intracellularly

• IV insulin (10 units) + glucose (50 mL 50%)

• Nebulised salbutamol (10–20 mg) as adjunct

• Sodium bicarbonate if acidosis present (after discussion with renal)

Step 3: Remove K⁺ from Body

• Calcium resonium orally/enema

• Loop diuretics (if kidneys working)

• Dialysis – most effective and definitive method

📌 Resistant/Refractory Hyperkalaemia
• Repeat insulin-dextrose
• Renal referral
• Dialysis for life-threatening or resistant cases
• Treat underlying cause and stop aggravating drugs

📌 Complications
• Cardiac arrhythmias (VF, asystole)
• Respiratory paralysis
• Sudden death
• Reversible with prompt recognition and treatment

📌 Prognosis
• Good if recognised early and managed quickly
• Prognosis worsens with delayed diagnosis, renal failure, or recurrent episodes

🔗 Hyperkalaemia Revision Resources
📄 Revision Notes: https://www.passthemsra.com/topic/hyperkalaemia-revision-notes/
💬 Flashcards: https://www.passthemsra.com/topic/hyperkalaemia-flashcards/
🧠 Accordion Q&A: https://www.passthemsra.com/topic/hyperkalaemia-accordion-qa-notes/
📝 Rapid Quiz: https://www.passthemsra.com/topic/hyperkalaemia-rapid-quiz/
📚 Course Hub: https://www.passthemsra.com/courses/renal-for-the-msra/

🏷️ Hashtags
#MSRA #MSRARevision #Hyperkalaemia #MSRANotes #MSRAFlashcards #MSRAQuiz #ECGChanges #RenalMedicine #MedicalRevision #PassTheMSRA #FreeMSRA #UKGuidelines #MedicalEmergency

🎧 FREE MSRA PODCAST – Henoch-Schönlein Purpura (HSP): The Classic Childhood Vasculitis

Revision overload? We break down HSP into the core clinical, diagnostic, and management essentials—perfect for MSRA and UK practice. Tetrads, triggers, complications, and what NOT to miss!

🧠 Key Learning Points

Definition
• HSP = IgA-mediated small vessel vasculitis, mostly in children.
• Affects: Skin, GI tract, joints, kidneys.

Classic Tetrad

1. Palpable purpura (non-blanching rash, typically lower limbs & buttocks)

2. Abdominal pain (may include GI bleeding, diarrhoea)

3. Arthralgia/arthritis (joint pain/swelling, especially knees/ankles)

4. Renal involvement (haematuria, proteinuria, rarely nephritic/nephrotic syndrome)

Causes & Triggers
• Often follows upper respiratory tract infection
• Other triggers: Medications, vaccinations, insect bites, various infections (Strep, EBV, Mycoplasma, Parvovirus B19, Coxsackie, Campylobacter, Varicella, Adenovirus)
• Rarely: Malignancy (especially adults)

Pathophysiology
• IgA immune complexes deposit in small vessel walls, activating complement → inflammation, increased permeability
• Leads to tissue damage in skin, joints, GI tract, kidneys

Differential Diagnosis
• Intussusception (as both complication & mimic)
• SLE/other connective tissue diseases
• Thrombocytopenia, meningococcal sepsis
• Other causes of glomerulonephritis or purpura
• Acute haemorrhagic oedema of infancy

Epidemiology (UK)
• Most common systemic vasculitis in children
• Peak: Ages 2–11 (esp. 4–6), slight male preponderance
• 10–20 per 100,000 children/year
• Seasonal: Winter/Spring (links to URTIs)

Clinical Features
• Preceding URTI common
• Rash: Palpable, non-blanching, lower limbs/buttocks
• Joint pain/swelling
• Abdominal pain, GI bleeding
• Renal: Haematuria, proteinuria
• May see: Low-grade fever, scrotal swelling, rare CNS symptoms

Diagnosis
• Clinical diagnosis (no single diagnostic test)
• Labs: Urinalysis (haematuria, proteinuria), FBC (normal/increased platelets), ESR (raised), serum creatinine (for renal function), IgA (often ↑ but non-specific), autoantibody screen (exclude SLE)
• Imaging: Abdominal USS for severe pain or suspected intussusception, testicular USS if scrotal symptoms
• Renal biopsy: If persistent/severe renal involvement

Management
• Mostly supportive: Paracetamol for pain, hydration, wound care
• NSAIDs with caution—avoid if GI/renal involvement
• Hospitalisation for severe pain, GI bleeding, or renal issues
• Steroids: May help pain, but not routinely for preventing/treating renal involvement in children
• Plasma exchange: Only in severe adult nephritis (not standard)

Prognosis & Complications
• Most recover fully, self-limiting (weeks–months)
• Renal involvement in up to 55%: Usually mild, rarely ESRD (<1%)
• Other: GI bleed, intussusception, testicular haemorrhage/torsion, CNS events (all rare)
• Recurrence in ~1/3 (esp. within 6 months)
• Follow-up essential: BP and urinalysis for delayed/ongoing renal issues

Memory Aid:
HSP = “IgA Purpura in Kids, Kidneys, Knees, and Gut”

📎 More HSP Revision Resources:
📝 Revision Notes: https://www.passthemsra.com/topic/henoch-schonlein-purpura-revision-notes/
💬 Flashcards: https://www.passthemsra.com/topic/henoch-schonlein-purpura-flashcards-2/
🧠 Q&A Notes: https://www.passthemsra.com/topic/henoch-schonlein-purpura-accordion-qa-notes-2/
📝 Rapid Quiz: https://www.passthemsra.com/topic/henoch-schonlein-purpura-rapid-quiz-2/
🎯 Quiz Portal: https://www.passthemsra.com/quizzes/henoch-schonlein-purpura-2/
📚 Renal Course: https://www.passthemsra.com/courses/renal-for-the-msra/

🏷️ #MSRA #HenochSchönleinPurpura #HSP #Vasculitis #Paediatrics #MSRARevision #MSRAFlashcards #MSRAQuiz #PassTheMSRA #FreeMSRA #Renal #SmallVesselVasculitis #Purpura #PaediatricNephrology #KidneyHealth #ChildrensHealth

⚕️ FREE MSRA PODCAST – Nephrogenic Diabetes Insipidus (NDI)
🎧 A high-yield breakdown of this renal ADH-resistance disorder. Perfect for mastering the water balance system in the kidneys and acing your exam questions.

🧠 Key Learning Points

📌 Definition
• NDI = kidneys fail to respond to ADH (vasopressin)
• Results in inability to concentrate urine → polyuria & polydipsia

📌 Causes & Risk Factors
• Congenital: Mutations in V2 receptor or aquaporin-2 channels
• Acquired:

• Lithium (classic MSRA link – ~30% develop NDI)

• Hypercalcaemia, hypokalaemia

• CKD, post-obstructive uropathy

• Medications: Demeclocycline, cisplatin
  • Risk factors: Lithium use, kidney disease, electrolyte imbalances, family history (congenital)

📌 Pathophysiology
• ADH signal is present, but kidneys can't respond
• Aquaporin insertion fails → water isn't reabsorbed → large volumes of dilute urine
• Collecting ducts are the main site of dysfunction

📌 Symptoms
• Polyuria, polydipsia, nocturia
• Very dilute urine, low osmolality
• Dehydration, fatigue
• In infants: failure to thrive, developmental delay

📌 Differential Diagnosis
• Central DI (brain issue, not kidney)
• Primary polydipsia
• Diabetes mellitus (osmotic diuresis)
• Hyperparathyroidism (via hypercalcaemia)

📌 Diagnosis
• Urine osmolality <300 mOsm/kg + plasma osmolality ↑
• Water deprivation test (gold standard):

• No increase in urine osmolality after desmopressin = NDI

• Significant increase = central DI
  • Check: serum Na⁺, Ca²⁺, K⁺, U&Es, lithium levels

📌 Management
• Maintain adequate hydration
• Low-salt & low-protein diet → ↓solute load
• Thiazide diuretics (e.g. hydrochlorothiazide) → paradoxically ↓ urine output
• Amiloride if on lithium or hypokalaemia
• NSAIDs (e.g. indomethacin) → reduce prostaglandin interference
• Desmopressin trial in partial NDI
• Treat the underlying cause (e.g. stop lithium, correct electrolytes)
• Scheduled fluid intake in infants to prevent dehydration
• Double voiding helps bladder emptying in children

📌 Complications
• Dehydration, electrolyte imbalance (esp. hyponatraemia, hyperkalaemia)
• UTIs, renal stones
• Long-term: chronic kidney disease if unmanaged

📌 Prognosis
• With good management, most patients do well
• Congenital NDI requires lifelong monitoring
• Prognosis depends on underlying cause & adherence to fluid/dietary management

📎 More MSRA Resources for Nephrogenic Diabetes Insipidus

📝 Revision Notes:
https://www.passthemsra.com/topic/nephrogenic-diabetes-insipidus-revision-notes/

🧠 Flashcards:
https://www.passthemsra.com/topic/nephrogenic-diabetes-insipidus-flashcards/

💬 Accordion Q&A Notes:
https://www.passthemsra.com/topic/nephrogenic-diabetes-insipidus-accordion-qa-notes/

🚀 Rapid Quiz:
https://www.passthemsra.com/topic/nephrogenic-diabetes-insipidus-rapid-quiz/

🧪 Topic Quiz:
https://www.passthemsra.com/quizzes/nephrogenic-diabetes-insipidus/

🎓 Full Renal Course:
https://www.passthemsra.com/courses/renal-for-the-msra/

🩺 All resources are part of the Renal for the MSRA course on PassTheMSRA.com
📚 Explore full revision guides, quizzes, flashcards, and more:
https://www.passthemsra.com

Hashtags
#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAFlashcards #MSRAQandANotes #MSRAAccordions #MSRAOnlineRevision #Renal #NephrogenicDiabetesInsipidus

💧 FREE MSRA PODCAST – Diabetes Insipidus
🎧 A clear, high-yield breakdown of this rare but important cause of polyuria and polydipsia – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• Diabetes Insipidus (DI) is a condition where the body fails to concentrate urine, leading to excessive water loss.
• It’s not related to blood sugar – it’s all about ADH (antidiuretic hormone) and water balance.

📌 Causes & Risk Factors
• Cranial DI: ADH deficiency
– Brain surgery
– Head trauma
– Pituitary tumours (e.g. craniopharyngioma)
– Infections (e.g. meningitis), sarcoidosis
• Nephrogenic DI: Renal resistance to ADH
– Lithium use 🚨
– Hypercalcaemia, hypokalaemia
– CKD
– Genetic mutations
• Other types:
– Gestational DI (placental enzyme degrades ADH)
– Primary polydipsia (excessive water intake)
🧠 Mnemonic: “Cranial = Can't make ADH, Nephrogenic = No kidney response”

📌 Pathophysiology
• ADH deficiency or resistance leads to failure to insert aquaporins → kidneys can’t reabsorb water → large volume of dilute urine.
• Blood becomes hyperosmolar, stimulating intense thirst.

📌 Symptoms
• Polyuria: often >3L/day (can reach 10–20L!)
• Polydipsia
• Nocturia, dry mouth, fatigue
• In infants: irritability, poor weight gain
🧠 C for Concentrated = Cranial DI response to desmopressin. N = Non-concentrated = Nephrogenic!

📌 Differential Diagnosis
• Diabetes mellitus (osmotic diuresis)
• Primary polydipsia
• Diuretic use
• Electrolyte imbalances: hypercalcaemia, hypokalaemia
• CKD, psychogenic causes

📌 Diagnosis
• Confirm polyuria (>3L/day)
• Serum osmolality: high/normal
• Urine osmolality: inappropriately low
• Water deprivation test: urine fails to concentrate
• Desmopressin trial:
– Urine concentrates = Cranial DI
– No change = Nephrogenic DI
🧠 C = Concentrated (Cranial), N = No change (Nephrogenic)
• MRI brain: look for pituitary/hypothalamic lesions if cranial DI

📌 Management
• Cranial DI:
– Desmopressin (DDAVP) replacement
– Monitor sodium to avoid hyponatraemia
• Nephrogenic DI:
– Identify and stop lithium if possible
– Correct electrolytes
– Ensure fluid access
– Thiazide diuretics paradoxically reduce urine output
– NSAIDs (e.g. indomethacin) may help
– High-dose desmopressin rarely used
🧠 “Thiazides for Thirst” in nephrogenic DI

📌 Complications
• Severe dehydration
• Electrolyte imbalance (especially sodium)
• UTIs, bladder distension
• Hydronephrosis in chronic untreated cases
• Hyponatraemia from desmopressin overuse
• Ischaemic heart disease: desmopressin may worsen symptoms

📌 Prognosis
• With proper diagnosis and management, prognosis is generally good
• Most patients live normal lives with long-term monitoring
• Prognosis depends on identifying and managing the underlying cause

📎 More MSRA Resources for Diabetes Insipidus
📝 Revision Notes:
https://www.passthemsra.com/topic/diabetes-insipidus-revision-notes/

🧠 Flashcards:
https://www.passthemsra.com/topic/diabetes-insipidus-flashcards/

💬 Accordion Q&A Notes:
https://www.passthemsra.com/topic/diabetes-insipidus-accordion-qa-notes/

🚀 Rapid Quiz:
https://www.passthemsra.com/topic/diabetes-insipidus-rapid-quiz/

🧪 Topic Quiz:
https://www.passthemsra.com/quizzes/diabetes-insipidus/

🎓 Full Course:
https://www.passthemsra.com/courses/renal-for-the-msra/

📣 All resources are part of the Renal for the MSRA course at
https://www.passthemsra.com – your go-to hub for NICE-based revision, flashcards, and rapid quizzes 🚀

Hashtags
#MSRA #MSRARevisionNotes #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #Renal #DiabetesInsipidus

⚕️ FREE MSRA PODCAST – Chronic Kidney Disease (CKD)
🎧 A clear, high-yield breakdown of this common, progressive cause of kidney dysfunction – perfect for exam prep and clinical practice.

🧠 Key Learning Points

📌 Definition
• CKD is a progressive and irreversible loss of kidney function over months/years.
• Defined by eGFR <60 or markers of kidney damage (e.g. albuminuria) for >3 months.

📌 Causes & Risk Factors
• Top 5 causes:

• Diabetic nephropathy

• Hypertension

• Chronic glomerulonephritis

• Chronic pyelonephritis

• Polycystic kidney disease
  • Risk factors:

• Diabetes, HTN, obesity, smoking

• Age >60, family history

• CVD

• Ethnicity (higher risk in Black, Asian, Hispanic)

📌 Pathophysiology
• Gradual nephron loss → ↓ filtration capacity
• Driven by:

• Fibrosis

• Chronic inflammation

• Oxidative stress

• Microvascular changes
  • Results in fluid/electrolyte imbalances + waste retention

📌 Symptoms
• Often asymptomatic in early stages
• Later features:

• Fatigue

• Nocturia

• Swelling (oedema)

• Pruritus, nausea, anorexia

• SOB, muscle cramps

• Uraemic foetor (ammonia breath)
  🧠 Clue: Nocturia is an early sign of CKD

📌 Differential Diagnosis
• Acute kidney injury (AKI)
• Acute-on-chronic kidney injury
• Diabetic nephropathy
• Polycystic kidney disease
• Obstructive uropathy

📌 Diagnosis
• eGFR <60 for >3 months = CKD
• Urine ACR – to assess proteinuria
• Bloods: U&Es, FBC, phosphate, calcium, bicarbonate
• Imaging: Renal USS for size/scarring
• Biopsy if uncertain cause
🧠 Tip: Combine GFR + ACR for accurate risk stratification

📌 Management
• Prescribing:

• ACEi/ARB – especially if ACR raised

• Statins – CV risk reduction

• SGLT2 inhibitors – kidney + cardiac protection

• Vitamin D, phosphate binders, bicarbonate as needed
  • Non-Prescribing:

• Smoking cessation, weight loss, dietary advice

• ↓ sodium, phosphate, protein intake
  • Monitoring:

• Regular eGFR + ACR checks

• Adjust meds for renal function
  • Referral to nephrology if:

• GFR <30 (Stage 4–5)

• Rapid progression (↓GFR ≥25% or ≥15mL/year)

• Refractory hypertension

• ACR ≥70

• Unclear cause or suspected renal artery stenosis

📌 Complications
• Anaemia
• Metabolic acidosis
• Secondary hyperparathyroidism / CKD-MBD
• Fluid overload
• Hyperkalaemia
• Cardiovascular disease
• Progression to end-stage renal disease (ESRD)

📌 Prognosis
• Variable – depends on cause, stage, progression
• Early detection + optimal BP/glucose control can slow progression
• CKD is a major risk factor for CV mortality

📎 More MSRA Resources for Chronic Kidney Disease (CKD)
📝 Revision Notes: https://www.passthemsra.com/topic/chronic-kidney-disease-ckd-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/chronic-kidney-disease-ckd-flashcards/
💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/chronic-kidney-disease-ckd-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/chronic-kidney-disease-ckd-rapid-quiz/
🎓 Full Course: https://www.passthemsra.com/courses/renal-for-the-msra/

Hashtags
#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQ&ANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #Renal #ChronicKidneyDisease

✅ MSRA Deep Dive: Bladder Cancer – High-Yield Revision
In this in-depth podcast episode, we break down bladder cancer into a clear, high-yield structure tailored for MSRA exam revision. Based on detailed, structured UK notes and NICE guidelines, we cover all key learning areas — from red flag symptoms like painless hematuria to staging, management, and complications. Whether you're preparing for your MSRA or looking to master urological oncology concepts efficiently, this is your concise yet comprehensive audio companion.

🧠 Key Learning Points

📌 Definition & Types
Bladder cancer is the abnormal growth of cells in the bladder lining, classified as:
• Non-muscle invasive vs. muscle-invasive
• Most common: Transitional cell carcinoma (TCC)
• Others: Squamous cell carcinoma (linked to chronic irritation) and adenocarcinoma

📌 Risk Factors
• Tobacco smoking – strongest modifiable risk
• Occupational exposures – dyes, rubber, textiles
• Age >65 years, male sex
• Chronic cystitis, bladder stones
• Pelvic radiotherapy, cyclophosphamide
• Parasitic infection (e.g., Schistosoma haematobium)
• HPV-16, Lynch syndrome, family history

📌 Symptoms & Red Flags
• Painless visible hematuria – most common first symptom
• Microscopic hematuria in >60s also warrants investigation
• Irritative voiding symptoms: frequency, urgency, dysuria
• Pelvic/perineal pain in later stages
• Advanced signs: ureteric obstruction, bone pain, weight loss, fatigue, jaundice

📌 Differential Diagnosis
• UTI
• Nephrolithiasis (kidney stones)
• Hemorrhagic cystitis
• Renal cancer, trauma, BPH

📌 Investigations
• Urinalysis, FBC, renal profile
• Cystoscopy with biopsy – gold standard
• Urine cytology – useful in CIS
• CT urogram for upper tract imaging
• Staging: CT chest/abdomen/pelvis, bone scan, LFTs, ALP
• NICE referral criteria:

• ≥45 with visible hematuria

• ≥60 with non-visible hematuria + dysuria or raised WBC

📌 Staging (TNM)
• Tis/Ta/T1 – non-muscle invasive
• T2+ – muscle-invasive
• N1-3 – pelvic lymph node spread
• M1 – distant metastasis

📌 Management
🔹 Non-muscle invasive (Tis, Ta, T1):
• TURBT (transurethral resection)
• Intravesical chemo (e.g., mitomycin C)
• BCG immunotherapy for high-risk cases

🔹 Muscle-invasive (T2+):
• Neoadjuvant chemotherapy (cisplatin)
• Radical cystectomy with pelvic lymph node dissection
• Urinary diversion (e.g., ileal conduit or neobladder)
• Adjuvant chemo or radiotherapy in selected cases

🔹 Metastatic disease:
• Cisplatin-based chemo
• If unfit: Carboplatin regimens, single agents
• Immunotherapy:

• Avelumab for maintenance

• Nivolumab post-op in high-risk cases

📌 Palliative Care
• Radiotherapy for bleeding or pain
• Stenting/nephrostomy for ureteral obstruction
• Embolisation or nerve blocks for pain relief

📌 Prognosis
• Tis/Ta/T1: 5-year survival 80–90%
• T2+: drops to 30–60%
• M1 (metastatic): ~10–15%
• High recurrence risk, requiring long-term surveillance
• Follow-up includes regular cystoscopy and upper tract imaging

📌 Complications
• Recurrence, UTIs, urinary retention, hydronephrosis
• ED and urinary incontinence post-surgery
• Bowel obstruction, infection, upper tract tumors

🔗 Bladder Cancer Resources for the MSRA
📄 Revision Notes: https://www.passthemsra.com/topic/bladder-cancer-revision-notes-2/
💬 Flashcards: https://www.passthemsra.com/topic/bladder-cancer-flashcards-2/
🧠 Accordion Q&A: https://www.passthemsra.com/topic/bladder-cancer-accordion-qa-notes-2/
📝 Rapid Quiz: https://www.passthemsra.com/topic/bladder-cancer-rapid-quiz-2/
📚 Course Hub: https://www.passthemsra.com/courses/renal-for-the-msra/

🏷️ Hashtags
#MSRA #MSRARevisionNotes #MSRATextbook #MSRAFlashcards #MSRAQuiz #MSRAQuestionBank #MSRAQANotes #MSRAAccordions #Renal #BladderCancer #UrologyMSRA #PainlessHematuria #UKGuidelines #PassTheMSRA #FreeMSRA

🎧 FREE MSRA PODCAST – Benign Prostatic Hypertrophy (BPH): The Ageing Prostate Explained!

Struggling to memorise all you need for BPH? This episode brings together the essential UK NICE-aligned facts, pathophysiology, investigations, management, and classic pitfalls—stripped down for MSRA revision and clinical practice!

🧠 Key Learning Points

Definition
• BPH = Benign (non-cancerous) increase in the number (hyperplasia, not hypertrophy) of glandular and stromal cells in the prostate, causing enlargement and compression of the urethra.
• Results in lower urinary tract symptoms (LUTS) – but LUTS is NOT specific to BPH!

Causes & Risk Factors
• Driven by hormonal changes, especially increased dihydrotestosterone (DHT) relative to testosterone
• Biggest risk factor: Ageing (commonest after 50, rare before 45)
• Others: Family history, obesity, diabetes, heart disease, hormonal imbalances
• Mnemonic: "A Family DHOH" (Age, Family, Diabetes, Heart, Obesity, Hormones)

Pathophysiology
• Hyperplasia (not hypertrophy!) in the transition zone around the urethra causes physical narrowing, increasing resistance to urine flow
• Symptoms arise from bladder outflow obstruction

Differential Diagnosis
• Must exclude prostate cancer!
• Others: UTI, bladder stones, strictures, bladder tumours, neurogenic bladder, chronic prostatitis

Epidemiology (UK)
• ~50% of men over 50 have histological BPH
• 40% of men in their 50s report symptoms; up to 90% by age 90
• Afro-Caribbean men at higher risk

Clinical Features
• Storage symptoms: Frequency, urgency, nocturia
• Voiding symptoms: Hesitancy, weak stream, straining, terminal dribble, incomplete emptying
• May lead to urinary retention, overflow incontinence, recurrent UTIs, bladder stones, and (rarely now) CKD

Diagnosis
• History and IPSS score
• DRE: Smooth, firm, enlarged prostate = BPH; hard/nodular = suspect cancer
• Urine dip: Exclude infection, check for blood
• PSA: To help rule out cancer
• Ultrasound: Assess prostate size, post-void residual, kidney/bladder health
• Uroflowmetry: Peak flow <10ml/s suggests obstruction
• Refer immediately for: Acute retention, AKI
• Two-week referral: Visible haematuria, suspicion of cancer, chronic retention with overflow

Management
• Lifestyle first: Fluid management, limit alcohol/caffeine, double voiding, physical activity
• Medications:
– Alpha-blockers (tamsulosin, alfuzosin): Relax smooth muscle, improve flow
– 5-alpha reductase inhibitors (finasteride, dutasteride): Shrink gland by lowering DHT
– Anticholinergics (oxybutynin): For storage symptoms (avoid if high PVR)
• Surgery:
– TURP (gold standard), HoLEP (laser), Urolift, Rezum, open prostatectomy for very large glands
• Complications: Recurrent UTIs, bladder stones, retention, CKD (rare), haematuria
• BPH is NOT pre-malignant! It does not increase cancer risk.

Memory Aids
• “Old men pee often, but not always well”
• BPH = “Bulk Produces Hesitation” (Bulk = hyperplasia, Produces Hesitation = voiding difficulty)

📎 More BPH Revision Resources:
📝 Revision Notes: https://www.passthemsra.com/topic/benign-prostatic-hypertrophy-bph-revision-notes/
💬 Flashcards: https://www.passthemsra.com/topic/benign-prostatic-hypertrophy-bph-flashcards/
🧠 Q&A Notes: https://www.passthemsra.com/topic/benign-prostatic-hypertrophy-bph-accordion-qa-notes/
📝 Rapid Quiz: https://www.passthemsra.com/topic/benign-prostatic-hypertrophy-bph-rapid-quiz/
🎯 Quiz Portal: https://www.passthemsra.com/quizzes/benign-prostatic-hypertrophy/
📚 Renal Course: https://www.passthemsra.com/courses/renal-for-the-msra/

🏷️ #MSRA #BenignProstaticHypertrophy #BPH #LUTS #Prostate #Urology #Renal #MSRARevision #MSRAFlashcards #MSRAQandA #ProstateHealth #TURP #Urolift #Rezum #HoLEP #ProstateCancer #PassTheMSRA #FreeMSRA #UKGuidelines